How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19?
Keywords:
COVID-19; isotretinoin; smell; taste, headache.Abstract
Introduction: It has been reported that the use of oral isotretinoin may have positive and negative effects on the course of COVID-19 and the risk of transmission.
Objectives: The purpose of our study is to evaluate how our patients that took oral isotretinoin during the pandemic were affected by COVID-19.
Methods: The clinical processes of moderate-to-severe acne vulgaris patients between March 2020 and February 2021 were evaluated.
Results: Of 102 moderate-to-severe acne patients, 67 were using oral isotretinoin and 35 were using a topical treatment. Of 27 patients who tested positive for COVID-19, 16 (59.3%) were using oral isotretinoin and 11(40.7%) were using topical treatment, there was no statistical difference in the rates of COVID-19 positivity between the two groups (P = 0.412). The rates of positive tests for COVID-19 were similar between contacted patients of two groups (P = 0.391). Loss of smell/taste was lower in patients using oral isotretinoin compared to patients receiving topical treatment (46.7% and 72.7%, respectively.). Headache symptoms were less common in patients using oral isotretinoin (P = 0.047).
Conclusions: The use of oral isotretinoin did not cause an increase or decrease in the risk of COVID-19 transmission. The patients using oral isotretinoin had a lower incidence of taste/smell loss and headache.
References
WHO announces COVID‐19 outbreak a pandemic. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed May 23, 2020.
Abdelmaksoud A, Lotti T, Anadolu R, et al. Low dose of isotretinoin: a comprehensive review. Dermatol Ther. 2020;33(2):e13251. DOI: 10.1111/dth.13251. PMID: 32022958.
Skroza N, Tolino E, Mambrin A, et al. Adult Acne Versus Adolescent Acne: A Retrospective Study of 1,167 Patients. J Clin Aesthet Dermatol. 2018;11(1):21-25. PMID: 29410726. PMCID: PMC5788264.
Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-637. doi:10.1002/path.1570. PMID: 15141377;.PMCID: PMC7167720.
Abdelmaksoud A, Vestita M, El-Amawy HS, Ayhan E, An İ, Öztürk M, Goldust M. Systemic isotretinoin therapy in the era of COVID-19. Dermatol Ther. 2020;33(4):e13482. DOI: 10.1111/dth.13482. PMID: 32358858. PMCID: PMC7261989.
Sinha S, Cheng K, Aldape K, Schiff E, Ruppin E. Systematic Cell Line-Based Identification of Drugs Modifying ACE2 Expression. Preprints. 2020, 2020030446. DOI: 10.20944/preprints202003.0446.v1.
Li R, Wu K, Li Y, et al. Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19. Aging (Albany NY). 2020;12(15):15784-15796. DOI:10.18632/aging.103888. PMID: 32805728. PMCID: PMC7467385.
Mawson AR, Croft AM, Gonzalez-Fernandez F. Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis. Viral Immunol. 2021;34(6):376-379. DOI: 10.1089/vim.2020.0330. PMID: 33983857. PMCID: PMC8392079.
Jovic TH, Ali SR, Ibrahim N, et al. Could Vitamins Help in the Fight Against COVID-19? Nutrients. 2020;12(9):2550. Published 2020;12(9):2550. doi:10.3390/nu12092550. PMID: 32842513. PMCID: PMC7551685.
Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449-1458. DOI:10.1002/jmv.26424. PMID: 32790106. PMCID: PMC7436673.
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-454. DOI:10.1038/nature02145. PMID: 14647384. PMCID: PMC7095016.
Demirel Öğüt N, Kutlu Ö, rbağcı E. Oral isotretinoin treatment in patients with acne vulgaris during the COVID-19 pandemic: A retrospective cohort study in a tertiary care hospital. J Cosmet Dermatol. 2021;20(7):1969-1974. DOI: 10.1111/jocd.14168. PMID: 33884755. PMCID: PMC8251193.
Lavezzo E. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature. 2020;584(7821):425–429.DOI: 10.1038/s41586-020-2488-1. PMID: 32604404.
Bolay H, Gül A, Baykan B. COVID-19 is a Real Headache!. Headache. 2020;60(7):1415-1421. DOI:10.1111/head.13856. PMID: 32412101. PMCID: PMC7272895.
Boscutti A, Delvecchio G, Pigoni A, et al. Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review. Brain Behav Immun Health. 2021;15:100268. DOI: 10.1016/j.bbih.2021.100268. PMID: 34027497. PMCID: PMC8129998.
Yee KK, Rawson NE. Immunolocalization of retinoic acid receptors in the mammalian olfactory system and the effects of olfactory denervation on receptor distribution. Neuroscience. 2005;131(3):733–743. DOI: 10.1016/j.neuroscience.2004.11.011. PMID: 15730877.
Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S. "Sniffin'sticks": screening of olfactory performance. Rhinology. 1996;34(4):222–226. PMID: 9050101.
Kartal D, Yaşar M, Kartal L, Özcan I, Borlu M. Effects of isotretinoin on the olfactory function in patients with acne. An Bras Dermatol. 2017;92(2):191-195. DOI: 10.1590/abd1806-4841.20175483. PMID: 28538877. PMCID: PMC5429103.
Published
Issue
Section
License
Copyright (c) 2022 Mine Müjde Kuş, Perihan Öztürk, Tutku Bulut, Celal Kuş, Mehmet Enes Güner, Hülya Nazik, Mehmet Kamil Mülayim
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
